You can buy or sell Novavax and other stocks, options, ETFs, and crypto commission-free!
Novavax, Inc. Common Stock, also called Novavax, is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. Read More It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. The firm's vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
52 Week High
52 Week Low
Novavax's 30% surge boosts biotech ETFs to best day in weeks
Exchange-traded funds with exposure to biotech stocks rocketed higher Tuesday on hopeful news about treatments for COVID-19. The ETFMG Treatments, Testing and A
Novavax CEO Talks $1.6B Federal Funding Win, Ex-FDA Chief Says It's A 'Good Bet'
The U.S. government awarded Novavax, Inc. (NASDAQ: NVAX) $1.6 billion in funding to support its COVID-19 vaccine, and the company is confident it has the capabi
— per share
Expected Aug 5, After Hours
Novavax Covid Vaccine Gets $1.6 Billion in U.S. Funding
(Bloomberg) -- Novavax Inc., one of the front-runners in the race to develop a Covid-19 vaccine, will receive $1.6 billion from the U.S. government, the biggest
Stocks making the biggest moves in the premarket: Novavax, Regeneron, Square, Nvidia & more
Take a look at some of the biggest movers in the premarket: Novavax (NVAX) – Novavax was awarded $1.6 billion in funding from "Operation Warp Speed," the gover
BRIEF-Novavax Announces $1.6 Billion Funding From Operation Warp Speed
July 7 (Reuters) - Novavax Inc: * NOVAVAX ANNOUNCES $1.6 BILLION FUNDING FROM OPERATION WARP SPEED * NOVAVAX INC - OWS AWARD FUNDS LARGE-SCALE MANUFACTURING O
Novavax shares soar 38% premarket on news of $1.6 billion in funding for COVID-19 vaccine candidate
Novavax Inc. NVAX, -2.69% said Tuesday it has received $1.6 billion in funding from the federal government's accelerated COVID-19 vaccine development program "O